Indivior PLC
Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly … Read more
Indivior PLC (INDV) - Total Liabilities
Latest total liabilities as of June 2025: GBX1.71 Billion GBX
Based on the latest financial reports, Indivior PLC (INDV) has total liabilities worth GBX1.71 Billion GBX as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Indivior PLC - Total Liabilities Trend (2011–2024)
This chart illustrates how Indivior PLC's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Indivior PLC Competitors by Total Liabilities
The table below lists competitors of Indivior PLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
EDENRED (QSV.SG)
STU:QSV
|
Germany | €13.86 Billion |
|
Gabelli Global Utility & Income Tr
NYSE MKT:GLU
|
USA | $247.50K |
|
LUMBER LIQ HLDG
BE:LKU
|
Germany | €393.61 Million |
|
Entergy Arkansas LLC Deb 2066
NYSE:EAI
|
USA | $108.87 Million |
|
BROWN NON VTG-B - Dusseldorf Stock Exchang
DU:BF5B
|
Germany | €4.74 Billion |
Liability Composition Analysis (2011–2024)
This chart breaks down Indivior PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.90 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -6.63 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Indivior PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Indivior PLC (2011–2024)
The table below shows the annual total liabilities of Indivior PLC from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | GBX1.67 Billion | -15.17% |
| 2023-12-31 | GBX1.97 Billion | +14.38% |
| 2022-12-31 | GBX1.72 Billion | +5.46% |
| 2021-12-31 | GBX1.63 Billion | +12.42% |
| 2020-12-31 | GBX1.45 Billion | +0.42% |
| 2019-12-31 | GBX1.44 Billion | -2.57% |
| 2018-12-31 | GBX1.48 Billion | -10.08% |
| 2017-12-31 | GBX1.65 Billion | +9.51% |
| 2016-12-31 | GBX1.50 Billion | +23.68% |
| 2015-12-31 | GBX1.22 Billion | -0.49% |
| 2014-12-31 | GBX1.22 Billion | +148.37% |
| 2013-12-31 | GBX492.00 Million | +19.42% |
| 2012-12-31 | GBX412.00 Million | +35.08% |
| 2011-12-31 | GBX305.00 Million | -- |